AISAP, an Israeli medical startup pioneering AI-driven diagnostics, has been recognized as one of the world’s most innovative and promising companies for 2025 by Fast Company. The company secured fourth place globally in the healthcare category, a remarkable achievement that underscores the international recognition of its groundbreaking technology and its impact on the future of medicine.

AISAP was founded by Adiel Am-Shalom, a former officer in Israel’s elite 8200 intelligence unit, alongside leading medical professionals: Professor Ehud Raanani, Professor Robert Klempner, and Professor Ehud Schwammenthal. The company has raised approximately $13 million in funding from investors including Harel Insurance, Shoni Health, and former Mossad director Tamir Pardo.

AISAP has developed AISAP CARDIO, the world’s first real-time AI-powered cardiac diagnostic platform. This technology enables life-saving bedside diagnostics, allowing for immediate and highly accurate detection of structural heart diseases and heart failure. The platform recently received FDA approval, marking a historic milestone in AI-driven medical diagnostics.

Keep reading at jpost.com.

AISAP Co-founder Ehud Raanani is a Technion alumnus.